Insomnia in older adults: A review of treatment options
- PMID: 39746731
- DOI: 10.3949/ccjm.92a.24073
Insomnia in older adults: A review of treatment options
Abstract
Insomnia is a common and challenging complaint in older adults (> 65 years) because of age-related alterations in sleep physiology. Cognitive behavioral therapy for insomnia is the gold standard for treatment of insomnia in young as well as older patients. Both clinicians and patients often prefer the simplicity of medication, but risks associated with some hypnotics increase with age. Pharmacologic options for older adults include low-dose doxepin, melatonin, ramelteon, and the dual orexin receptor antagonists. A well-informed clinician can help patients navigate the risks and benefits of both pharmacologic and behavioral options.
Copyright © 2025 The Cleveland Clinic Foundation. All Rights Reserved.
Similar articles
-
Insomnia management.Aust J Gen Pract. 2019 Apr;48(4):198-202. Aust J Gen Pract. 2019. PMID: 31256489
-
Insomnia: Pharmacologic Treatment.Clin Geriatr Med. 2021 Aug;37(3):401-415. doi: 10.1016/j.cger.2021.04.003. Epub 2021 Jun 4. Clin Geriatr Med. 2021. PMID: 34210446 Review.
-
Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.Ann Intern Med. 2016 Jul 19;165(2):103-12. doi: 10.7326/M15-1781. Epub 2016 May 3. Ann Intern Med. 2016. PMID: 27136278 Review.
-
An update of management of insomnia in patients with chronic orofacial pain.Oral Dis. 2017 Nov;23(8):1043-1051. doi: 10.1111/odi.12637. Epub 2017 Feb 22. Oral Dis. 2017. PMID: 28075519 Review.
-
A Review of Suvorexant, Doxepin, Ramelteon, and Tasimelteon for the Treatment of Insomnia in Geriatric Patients.Consult Pharm. 2017 Mar 1;32(3):156-160. doi: 10.4140/TCP.n.2017.156. Consult Pharm. 2017. PMID: 28270270 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical